Home › Trial NCT00399789
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
- Trial IDNCT00399789
- StatusCompleted
- PhasePhase 1/2
- Study typeInterventional
- SponsorAEterna Zentaris
- Enrollment121
- Start date2004-09
- ConditionsNon Small Cell Lung Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Human verification coming soon — the enriched analysis will be viewable here.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.